Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

Published:2023-10 Issue: Volume:147 Page:155663
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Fernández-Sáez Eva M.,Losarcos Maite,Becerril Sara,Valentí Víctor,Moncada Rafael,Martín Marina,Burrell María A.,Catalán Victoria,Gómez-Ambrosi Javier,Mugueta Carmen,Colina Inmaculada,Silva Camilo,Escalada Javier,Frühbeck Gema,Rodríguez Amaia

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference64 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

2. Impact of nutritional changes on nonalcoholic fatty liver disease;Perdomo;Nutrients.,2019

3. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis;Younossi;J Hepatol,2019

4. Mechanisms and disease consequences of nonalcoholic fatty liver disease;Loomba;Cell.,2021

5. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD;Tamaki;Nat Rev Endocrinol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease;Clinical Nutrition;2024-09

2. Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD;Metabolism;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP